Should I buy or sell Aemetis stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aemetis in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" AMTX shares. View AMTX analyst ratings or view top-rated stocks .

What is Aemetis' stock price target for 2024?

4 Wall Street analysts have issued 1 year price objectives for Aemetis' shares. Their AMTX share price targets range from $3.00 to $28.00. On average, they predict the company's stock price to reach $10.30 in the next year. This suggests a possible upside of 184.5% from the stock's current price. View analysts price targets for AMTX or view top-rated stocks among Wall Street analysts .

How have AMTX shares performed in 2024?

Aemetis' stock was trading at $5.24 at the start of the year. Since then, AMTX stock has decreased by 30.9% and is now trading at $3.62. View the best growth stocks for 2024 here .

Are investors shorting Aemetis?

Aemetis saw a increase in short interest in March. As of March 31st, there was short interest totaling 5,320,000 shares, an increase of 14.7% from the March 15th total of 4,640,000 shares. Based on an average daily volume of 1,220,000 shares, the short-interest ratio is presently 4.4 days. View Aemetis' Short Interest .

When is Aemetis' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024. View our AMTX earnings forecast .

How were Aemetis' earnings last quarter?

Aemetis, Inc. (NASDAQ:AMTX) posted its quarterly earnings data on Thursday, March, 7th. The specialty chemicals company reported ($0.34) earnings per share for the quarter, beating the consensus estimate of ($0.35) by $0.01. The specialty chemicals company had revenue of $70.76 million for the quarter, compared to analyst estimates of $80.08 million. During the same period in the previous year, the company posted ($0.63) earnings per share.

What ETF holds Aemetis' stock?

Invesco Dorsey Wright Energy Momentum ETF holds 189,235 shares of AMTX stock, representing 1.60% of its portfolio.

What other stocks do shareholders of Aemetis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aemetis investors own include Pennsylvania Real Estate Investment Trust (PEI) , Zosano Pharma (ZSAN) , CNBX Pharmaceuticals (CNBX) , Gran Tierra Energy (GTE) , Tilly's (TLYS) , Auxly Cannabis Group (CBWTF) , Novan (NOVN) , Aeterna Zentaris (AEZS) , American Cannabis (AMMJ) and Bionano Genomics (BNGO) .

How do I buy shares of Aemetis?

Shares of AMTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:AMTX

Aemetis (AMTX) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free AMTX Stock Alerts

$3.71

+0.09 (+2.49%)

(As of 11:33 AM ET)

Compare

Today's Range: $3.60
▼
$3.73
50-Day Range: $2.89
▼
$6.02
52-Week Range: $1.16
▼
$8.99

Volume: 206,367 shs
Average Volume: 1.15 million shs
Market Capitalization: $158.08 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $10.30

Get Aemetis alerts:

Aemetis MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.75 Rating Score
Upside/Downside: 184.5% Upside
$10.30 Price Target
Short Interest: Bearish
12.49% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.93
Based on 3 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($1.44) to ($0.24) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.62 out of 5 stars

Oils/Energy Sector

189th out of 233 stocks

Industrial Organic Chemicals Industry

15th out of 18 stocks

3.4

Analyst's Opinion

Consensus Rating
Aemetis has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.
Amount of Analyst Coverage
Aemetis has only been the subject of 2 research reports in the past 90 days.

1.0

Short Interest

Percentage of Shares Shorted
12.49% of the outstanding shares of Aemetis have been sold short.
Short Interest Ratio / Days to Cover
Aemetis has a short interest ratio ("days to cover") of 4.4.
Change versus previous month
Short interest in Aemetis has recently increased by 14.66%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Aemetis does not currently pay a dividend.
Dividend Growth
Aemetis does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for AMTX.

3.8

News and Social Media Coverage

News Sentiment
Aemetis has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.53 average news sentiment score of Oils/Energy companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for Aemetis this week, compared to 2 articles on an average week.
Search Interest
27 people have searched for AMTX on MarketBeat in the last 30 days. This is an increase of 238% compared to the previous 30 days.
MarketBeat Follows
4 people have added Aemetis to their MarketBeat watchlist in the last 30 days. This is an increase of 33% compared to the previous 30 days.

0.8

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Aemetis insiders have not sold or bought any company stock.
Percentage Held by Insiders
14.34% of the stock of Aemetis is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 27.02% of the stock of Aemetis is held by institutions.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Aemetis are expected to grow in the coming year, from ($1.44) to ($0.24) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Aemetis is -2.74, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Aemetis is -2.74, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

See Top Rated MarketRank™ Stocks Here

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About Aemetis Stock (NASDAQ:AMTX)

Aemetis, Inc. operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products. In addition, it produces and sells ethanol; and wet distillers grains, distillers corn oil, and condensed distillers solubles to dairies and feedlots as animal feed. Further, the company markets and supplies USP alcohol and hand sanitizer; and produces renewable natural gas, as well as distilled biodiesel from various vegetable oil and animal waste feedstocks. Additionally, it researches and develops conversion technologies using waste feedstocks to produce biofuels and biochemicals. Furthermore, it sells biodiesel primarily to government oil marketing companies. Aemetis, Inc. is headquartered in Cupertino, California.

AMTX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

AMTX Stock News Headlines

April 18, 2024 | markets.businessinsider.com

Piper Sandler Keeps Their Sell Rating on Aemetis (AMTX)

April 18, 2024 | investorplace.com

7 Penny Growth Stocks to Buy ASAP Before They Go Parabolic

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

April 12, 2024 | americanbankingnews.com

Aemetis (NASDAQ:AMTX) Shares Pass Below 200 Day Moving Average of $4.34

April 12, 2024 | americanbankingnews.com

Aemetis (NASDAQ:AMTX) Shares Cross Below 200-Day Moving Average of $4.34

April 9, 2024 | msn.com

Aemetis awarded $10.5M in federal tax credits for biofuels projects

April 9, 2024 | finance.yahoo.com

Aemetis Allocated $10.5 Million IRA Section 48C Tax Credits by DOE and IRS for Biofuels Plant Efficiency Projects

April 4, 2024 | markets.businessinsider.com

Buy Rating Affirmed: Aemetis’s Growth and Prospects Outweigh Risks

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

April 1, 2024 | finance.yahoo.com

Aemetis Implements Microsoft Dynamics(TM) ERP System to Support Current Operations and Expansion Projects

April 1, 2024 | globenewswire.com

Aemetis Implements Microsoft Dynamics(TM) ERP System to Support Current Operations and Expansion Projects

March 23, 2024 | wsj.com

Aemetis Inc.

March 22, 2024 | msn.com

Aemetis (NASDAQ:AMTX) is a Prime ESG Investment Opportunity

March 22, 2024 | seekingalpha.com

Aemetis CEO Interview - A Biofuel Company With 10x+ Upside

March 21, 2024 | marketwatch.com

Aemetis Shares Rise on Approval for $200 Million EB-5 Program

March 21, 2024 | msn.com

Aemetis surges after USCIS approves $200M for renewable energy projects

March 21, 2024 | finance.yahoo.com

Aemetis Approved by USCIS for $200 million of EB-5 Investment in Biogas, SAF and Carbon Sequestration Projects

March 20, 2024 | finance.yahoo.com

AMTX Jan 2025 7.500 put

March 20, 2024 | finance.yahoo.com

AMTX May 2024 3.500 call

March 16, 2024 | ca.finance.yahoo.com

AMTX Apr 2024 3.500 put

March 14, 2024 | finance.yahoo.com

AMTX Mar 2024 3.000 put

March 14, 2024 | finance.yahoo.com

When Will Aemetis, Inc. (NASDAQ:AMTX) Breakeven?

March 11, 2024 | finance.yahoo.com

AMTX Jul 2024 10.000 put

March 9, 2024 | seekingalpha.com

Aemetis, Inc. (AMTX) Q4 2023 Earnings Call Transcript

March 8, 2024 | markets.businessinsider.com

Aemetis: Poised for Growth with Sustainable Fuels and Strong Performance – Buy Rating Affirmed

March 8, 2024 | finance.yahoo.com

Aemetis, Inc. (NASDAQ:AMTX) Q4 2023 Earnings Call Transcript

March 7, 2024 | finanznachrichten.de

Aemetis, Inc.: Aemetis Reports 2023 Fourth Quarter and Year-End Results

See More Headlines

Receive AMTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aemetis and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/07/2024
Today: 4/19/2024
Next Earnings (Estimated): 5/02/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Oils/Energy
Industry: Industrial organic chemicals
Sub-Industry: N/A
Current Symbol: NASDAQ:AMTX
CUSIP: N/A
CIK: 738214
Web: www.aemetis.com
Phone: (408) 213-0940
Fax: 408-252-8044
Employees: 205
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $10.30
High Stock Price Target: $28.00
Low Stock Price Target: $3.00
Potential Upside/Downside: +184.5%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.75
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.32)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-46,420,000.00
Net Margins: -24.86%
Pretax Margin: -53.64%
Return on Equity: N/A
Return on Assets: -43.11%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.43
Quick Ratio: 0.21

Sales & Book Value

Annual Sales: $186.72 million
Price / Sales: 0.83
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($5.49) per share
Price / Book: -0.66

Miscellaneous

Outstanding Shares: 42,610,000
Free Float: 36,499,000
Market Cap: $154.25 million
Optionable: Optionable
Beta: 1.01

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

Mr. Eric A. McAfee (Age 61)
Co-Founder, Executive Chairman & CEO
Comp: $460k
Mr. Todd A. Waltz (Age 63)
Executive VP & CFO
Comp: $371k
Mr. Andrew B. Foster (Age 59)
Executive VP & COO
Comp: $361.94k
Mr. Sanjeev Gupta (Age 64)
Executive Vice President of Aemetis International
Comp: $376.25k
Mr. J. Michael Rockett
Executive VP, General Counsel & Corporate Secretary

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

AMTX Stock Analysis - Frequently Asked Questions

Should I buy or sell Aemetis stock right now?: 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aemetis in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" AMTX shares.
View AMTX analyst ratings or view top-rated stocks.
What is Aemetis' stock price target for 2024?: 4 Wall Street analysts have issued 1 year price objectives for Aemetis' shares. Their AMTX share price targets range from $3.00 to $28.00. On average, they predict the company's stock price to reach $10.30 in the next year. This suggests a possible upside of 184.5% from the stock's current price.
View analysts price targets for AMTX or view top-rated stocks among Wall Street analysts.
How have AMTX shares performed in 2024?: Aemetis' stock was trading at $5.24 at the start of the year. Since then, AMTX stock has decreased by 30.9% and is now trading at $3.62.
View the best growth stocks for 2024 here.
Are investors shorting Aemetis?: Aemetis saw a increase in short interest in March. As of March 31st, there was short interest totaling 5,320,000 shares, an increase of 14.7% from the March 15th total of 4,640,000 shares. Based on an average daily volume of 1,220,000 shares, the short-interest ratio is presently 4.4 days.
View Aemetis' Short Interest.
When is Aemetis' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our AMTX earnings forecast.

How were Aemetis' earnings last quarter?: Aemetis, Inc. (NASDAQ:AMTX) posted its quarterly earnings data on Thursday, March, 7th. The specialty chemicals company reported ($0.34) earnings per share for the quarter, beating the consensus estimate of ($0.35) by $0.01. The specialty chemicals company had revenue of $70.76 million for the quarter, compared to analyst estimates of $80.08 million. During the same period in the previous year, the company posted ($0.63) earnings per share.
What ETF holds Aemetis' stock?: Invesco Dorsey Wright Energy Momentum ETF holds 189,235 shares of AMTX stock, representing 1.60% of its portfolio.
What other stocks do shareholders of Aemetis own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Aemetis investors own include Pennsylvania Real Estate Investment Trust (PEI), Zosano Pharma (ZSAN), CNBX Pharmaceuticals (CNBX), Gran Tierra Energy (GTE), Tilly's (TLYS), Auxly Cannabis Group (CBWTF), Novan (NOVN), Aeterna Zentaris (AEZS), American Cannabis (AMMJ) and Bionano Genomics (BNGO).
How do I buy shares of Aemetis?: Shares of AMTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:AMTX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Aemetis (AMTX) Stock Price, News & Analysis

Aemetis MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Aemetis Stock (NASDAQ:AMTX)

AMTX Stock Price History

AMTX Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

AMTX Stock Analysis - Frequently Asked Questions

Overall MarketRank^™